skip to Main Content

News

Latest News, Announcements, and Press Releases

26May 15

“Evolving BVMO’s” – Codexis Feature in Chemistry Today

Oxidation reactions can be a challenge for the chemicals industry with concerns about safety, selectivity, side reactions and over oxidations. Codexis is using biocatalysis to overcome these challenges and has recently evolved a novel Baeyer-Villiger monooxygenase (BVMO) enzyme. The enzyme…
read more
05May 15

Codexis to Present at May Investor Conferences

REDWOOD CITY, Calif., May 5, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that management will present at two investor conferences in May: Senior Vice…
read more
30Apr 15

Codexis to Hold 2015 First Quarter Conference Call on May 7

REDWOOD CITY, Calif., April 30, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it will report first quarter 2015 financial results after market close…
read more
03Mar 15

Codexis Reports 2014 Fourth Quarter and Full Year Results

Achieves First Milestone Payment from GSK Introduces 2015 financial guidance — Conference call begins at 4:30 p.m. Eastern time today — REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins® with Codexis

Back To Top
Close search
Search